US 10,703,781 B2Granted

Piscine myocarditis virus-like particles and methods of use thereof

AssigneePharmaq AS

InventorsPal Nilsen, Marit Rode

Life of this patent

Estimating the term…

Abstract

The present invention relates to a piscine myocarditis virus (PMCV) virus-like particle (VLP) which consists only of PMCV ORF1 protein.

Claims14

Dependent claims

A recombinant piscine myocarditis virus (PMCV) virus-like particle (VLP) comprising a PMCV ORF1 protein, having at least about 90% sequence identity to the sequence comprising SEQ ID No:

Dependencies are inferred from the claim text.

Facts

Application: 16/544,060Filed 19 Aug 2019 · continuation
Priority: 30 Jan 2018
Published: US 2020/0002385 A12 Jan 2020
Granted: 7 Jul 2020
Term ends: Not estimatedThe source records don’t support an estimate.

Classification15 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
A61K 39/12
Medicinal preparations containing antigens or antibodies: viral antigens
C12N 7/00
Viruses
C12N 15/85
Vectors or expression systems specially adapted for eukaryotic hosts: for animal cells

Family

Application15/883,202Parent of this continuation · filed 30 Jan 2018
US 2020/0002385 A1Pre-grant publication · published 2 Jan 2020
US 10,428,117 B2Parent of this continuation
US 2018/0215793 A1Published application
US 10,703,781 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results